Athira Pharma to Participate in Upcoming October Conferences
Get Alerts ATHA Hot Sheet
Join SI Premium – FREE
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the following upcoming investor conferences in October.
Goldman Sachs Alzheimer’s Disease DayFormat: Panel Presentation Date and Time: Tuesday, October 3, 2023, from 10:00 a.m. ET- 11:00 a.m. ET Location: Goldman Sachs Conference Center, New York City
JonesTrading 2023 Healthcare SummitFormat: Investor MeetingsInvestors interested in meeting with Athira management during the JonesTrading Conference, please reach out to your JonesTrading representative or contact Julie Rathbun at [email protected].Dates: October 9-11 Location: Eden Roc, Miami
Jefferies Inaugural Biotech CNS/Neuro Summit Format: Fireside ChatDate and Time: Thursday, October 12, 2023, at 8:30 a.m. ETLocation: Jefferies Conference Center, New York City
Live webcasts of the panel and presentations can be accessed from the Investors section of the Athira website at https://investors.athira.com/news-and-events/events-and-presentations-investor. An archived replay of the webcasts will be available for at least 30 days following the event.
About Athira Pharma, Inc.Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to alter the course of neurological disease by advancing its pipeline of therapeutic candidates targeting the neurotrophic HGF system for Alzheimer’s and Parkinson’s disease, Dementia with Lewy bodies, and amyotrophic lateral sclerosis. For more information, visit www.athira.com. You can also follow Athira on Facebook, LinkedIn, X (formerly known as Twitter) and Instagram.
Investor & Media Contact:
Julie RathbunAthira Pharma[email protected]206-769-9219
Source: Athira Pharma, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mavro Asset Ecosystem Announces August 17 Launch of Public Token Sale on PinkSale
- Crypto Price Prediction Flashes Mixed Signals While Pepeto Storms Toward Its Debut
- ComEd Restores Power to 99% of Customers Impacted by Aug. 11-12 Storms
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share